Anti-ATE1 antibody [EPR13667(2)] - N-terminal,Abcam,AB199423

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Mouse, Rat, Human

Application

IHC-P, Flow Cyt (Intra), WB

Platform ID

BAB342402448

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-ATE1 antibody [EPR13667(2)] - N-terminal
Cat. No.AB199423
HostRabbit
IsotypeIgG
ReactivityMouse, Rat, Human
ApplicationIHC-P, Flow Cyt (Intra), WB
ClonalityMonoclonal
Clone NumberEPR13667(2)
Concentration1.194 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Involved in the post-translational conjugation of arginine to the N-terminal aspartate or glutamate of a protein (PubMed : 34893540). This arginylation is required for degradation of the protein via the ubiquitin pathway (PubMed : 34893540). Does not arginylate cysteine residues (By similarity). See full target information ATE1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.